Ocular Therapeutix Inc (OCUL)
9.50
+6.09%
Ocular Therapeutix Inc (OCUL) is currently trading at $9.50. This represents a gain of 6.09% from the previous session. With a market capitalization of $2.07B, OCUL is a key component of the Health Care sector. Investors looking to trade OCUL should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade OCUL commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Ocular Therapeutix Inc (OCUL) shows a bullish trend. Analysts are watching the 9.76 level closely.
Fundamentals
Mkt Cap2.07B
P/E Ratio0.0000
Volume7,848,260
60-Day Technical Chart
Advanced Charting
Need more indicators for OCUL? Use the world's #1 platform.
Open OCUL on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $10
| Metric |
OCUL +6.09% |
IBRX -17.40% |
ONDS -0.96% |
MARA +6.46% |
|---|---|---|---|---|
| Price | $9.50 | $9.54 | $10.30 | $8.57 |
| Mkt Cap | $2.07B | $9.81B | $4.35B | $3.24B |
| - | View → | View → | View → |
Latest Headlines
3 Reasons OCUL is Risky and 1 Stock to Buy Instead
Yahoo Finance • Jan 13, 2026
Landmark eye trial: two-thirds on AXPAXLI kept vision at 1 year
Stock Titan • Feb 17, 2026
OCUL stock surges overnight ahead of crucial wet AMD data readout, Sanofi takeover buzz builds
MSN • Feb 25, 2026
Ocular Therapeutix stock news: Why positive data led to a 25% drop
Investing.com • Feb 17, 2026
Ocular Therapeutix (OCUL) Is Down 5.8% After AXPAXLI Phase 3 Update And New Share Registration – What's Changed
simplywall.st • Feb 16, 2026
● Gemini Agentic AI Analyst Insight for OCUL
Market Education
- Stocks with Cash and Low Debt Dec 10, 2023
- Investing $100: Options and Tools for Small Investments - many drops make an Ocean Jul 15, 2023
- What is Pattern Day Trading rule (PDT) - Its limiting my trading. Jul 15, 2023
External Research